相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Coupling of β1-adrenergic receptor to type 5 adenylyl cyclase and its physiological relevance in cardiac myocytes
Takashi Tsunematsu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
A PKM2 signature in the failing heart
Meredith L. Rees et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Loss of Glycogen Synthase Kinase 3 Isoforms During Murine Oocyte Growth Induces Offspring Cardiac Dysfunction
Andre Monteiro da Rocha et al.
BIOLOGY OF REPRODUCTION (2015)
Role for engagement of-arrestin2 by the transactivated EGFR in agonist-specific regulation of receptor activation of ERK1/2
Le-Sha Zhang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia
Lucila H. Oliveira et al.
CANCER SCIENCE (2015)
Overexpression of protein phosphatase 2A in a murine model of chronic myocardial infarction leads to increased adverse remodeling but restores the regulation of β-catenin by glycogen synthase kinase 3β
M. Hoehn et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Hyperphosphate-Induced Myocardial Hypertrophy through the GATA-4/NFAT-3 Signaling Pathway Is Attenuated by ERK Inhibitor Treatment
Yao-Lung Liu et al.
CardioRenal Medicine (2015)
Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction
Christian Schulte et al.
WORLD JOURNAL OF CARDIOLOGY (2015)
γ-tubulin is differentially expressed in mitotic and non-mitotic cardiomyocytes in the regenerating zebrafish heart
Pauline Sallin et al.
DATA IN BRIEF (2015)
A miR-208-Mef2 Axis Drives the Decompensation of Right Ventricular Function in Pulmonary Hypertension
Roxane Paulin et al.
CIRCULATION RESEARCH (2015)
The GSK-3 Family as Therapeutic Target for Myocardial Diseases
Hind Lal et al.
CIRCULATION RESEARCH (2015)
Serelaxin: A Novel Therapy for Acute Heart Failure with a Range of Hemodynamic and Non-Hemodynamic Actions
Javier Diez
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2014)
MicroRNA-133 Modulates the β1-Adrenergic Receptor Transduction Cascade
Alessandra Castaldi et al.
CIRCULATION RESEARCH (2014)
Natriuretic peptides in cardiovascular diseases: current use and perspectives
Massimo Volpe et al.
EUROPEAN HEART JOURNAL (2014)
Targeting the Wnt pathway in zebrafish as a screening method to identify novel therapeutic compounds
Joshua K. Robertson et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2014)
The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy
Jenny Y. Y. Ooi et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Cardiomyocyte-Specific Deletion of Gsk3α Mitigates Post-Myocardial Infarction Remodeling, Contractile Dysfunction, and Heart Failure
Firdos Ahmad et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Inhibition of miR-25 improves cardiac contractility in the failing heart
Christine Wahlquist et al.
NATURE (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Silencing of miR-34a Attenuates Cardiac Dysfunction in a Setting of Moderate, but Not Severe, Hypertrophic Cardiomyopathy
Bianca C. Bernardo et al.
PLOS ONE (2014)
The switching role of β-adrenergic receptor signalling in cell survival or death decision of cardiomyocytes
Sung-Young Shin et al.
NATURE COMMUNICATIONS (2014)
Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date
Antonino Tuttolomondo et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2014)
β-Adrenergic Regulation of Cardiac Progenitor Cell Death Versus Survival and Proliferation
Mohsin Khan et al.
CIRCULATION RESEARCH (2013)
TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophy
Tatyana Novoyatleva et al.
CYTOKINE (2013)
Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
Marco Metra et al.
EUROPEAN HEART JOURNAL (2013)
Baicalein protects against cardiac hypertrophy through blocking MEK-ERK1/2 signaling
Jing Zong et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
MicroRNA-34a regulates cardiac ageing and function
Reinier A. Boon et al.
NATURE (2013)
Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure
Ellen Dirkx et al.
NATURE CELL BIOLOGY (2013)
PGC1α Plays a Critical Role in TWEAK-Induced Cardiac Dysfunction
Jianru Shi et al.
PLOS ONE (2013)
Lithium: the pharmacodynamic actions of the amazing ion
Kayleigh M. Brown et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2013)
Thrombospondin-4, tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14: Novel extracellular matrix modulating factors in cardiac remodelling
Erja Mustonen et al.
ANNALS OF MEDICINE (2012)
Transforming Growth Factor-β-Induced Endothelial-to-Mesenchymal Transition Is Partly Mediated by MicroRNA-21
Regalla Kumarswamy et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death
Arin B. Aurora et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Increased BRAF Heterodimerization Is the Common Pathogenic Mechanism for Noonan Syndrome-Associated RAF1 Mutants
Xue Wu et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
The role of TWEAK/Fn14 in cardiac remodeling
Man-Yi Ren et al.
MOLECULAR BIOLOGY REPORTS (2012)
TWEAK/Fn14 promotes the proliferation and collagen synthesis of rat cardiac fibroblasts via the NF-κB pathway
Hui-Na Chen et al.
MOLECULAR BIOLOGY REPORTS (2012)
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
Scott D. Solomon et al.
LANCET (2012)
Swimming Training in Rats Increases Cardiac MicroRNA-126 Expression and Angiogenesis
Natan D. Da Silva et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2012)
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy
Ahmet Ucar et al.
NATURE COMMUNICATIONS (2012)
miR-15 Family Regulates Postnatal Mitotic Arrest of Cardiomyocytes
Enzo R. Porrello et al.
CIRCULATION RESEARCH (2011)
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
C. M. O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
MicroRNAs in cardiac disease
Gerald W. Dorn
TRANSLATIONAL RESEARCH (2011)
FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK
Emmanuel Chorianopoulos et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
TWEAK is a positive regulator of cardiomyocyte proliferation
Tatyana Novoyatleva et al.
CARDIOVASCULAR RESEARCH (2010)
Calmodulin-Dependent Kinase II Mediates Vascular Smooth Muscle Cell Proliferation and Is Potentiated by Extracellular Signal Regulated Kinase
E. Cipolletta et al.
ENDOCRINOLOGY (2010)
Cardiac overexpression of insulin-like growth factor 1 attenuates chronic alcohol intake-induced myocardial contractile dysfunction but not hypertrophy: Roles of Akt, mTOR, GSK3β, and PTEN
Bingfang Zhang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study
Luis Miguel Ruilope et al.
LANCET (2010)
MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling
Paula A. da Costa Martins et al.
NATURE CELL BIOLOGY (2010)
A Novel Role for Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK) in the Development of Cardiac Dysfunction and Failure
Mohit Jain et al.
CIRCULATION (2009)
Intravenous Recombinant Human Relaxin in Compensated Heart Failure: A Safety, Tolerability, and Pharmacodynamic Trial
Thomas Dschietzig et al.
JOURNAL OF CARDIAC FAILURE (2009)
Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia
Ana B. Sanz et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Noonan syndrome is associated with enhanced pERK activity, the repression of which can prevent craniofacial malformations
Tomoki Nakamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Angelika Bonauer et al.
SCIENCE (2009)
Distinct roles of GSK-3α and GSK-3β phosphorylation in the heart under pressure overload
Takahisa Matsuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inhibition of glycogen synthase kinase 3β during heart failure is protective
Shinichi Hirotani et al.
CIRCULATION RESEARCH (2007)
Glycogen synthase kinase-3α reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases
Peiyong Zhai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Activation of MAPK in hearts of EMD null mice:: similarities between mouse models of X-linked and autosomal dominant Emery-Dreifuss muscular dystrophy
Antoine Muchir et al.
HUMAN MOLECULAR GENETICS (2007)
β-Catenin downregulation is required for adaptive cardiac remodeling
Anthony Baurand et al.
CIRCULATION RESEARCH (2007)
MicroRNA-133 controls cardiac hypertrophy
Alessandra Care et al.
NATURE MEDICINE (2007)
Proper chromatin condensation and maintenance of histone H3 phosphorylation during mouse oocyte meiosis requires protein phosphatase activity
Jason E. Swain et al.
BIOLOGY OF REPRODUCTION (2007)
Timeline - The twentieth century struggle to decipher insulin signalling
Philip Cohen
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes
Ai-Sun Tseng et al.
CHEMISTRY & BIOLOGY (2006)
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Controversies in Cardiology 4 - Controversies in ventricular remodelling
LH Opie et al.
LANCET (2006)
Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure
T Ueland et al.
CIRCULATION (2005)
Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the 'real world' of therapy
M Suwa et al.
CIRCULATION JOURNAL (2005)
The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFκB pathway activation and BCL-XL/BCL-W expression
NL Tran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Omapatrilat and enalapril in patients with hypertension: The omapatrilat cardiovascular treatment vs. enalapril (OCTAVE) trial
OB Kostis et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
Changes in β-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system
R Sethi et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2004)
Glycogen synthase kinase-3β regulates growth, calcium homeostasis, and diastolic function in the heart
A Michael et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation
M Illario et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR - Evidence for a second TWEAK receptor
TC Polek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Stabilization of β-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth
S Haq et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter
A Sanbe et al.
CIRCULATION RESEARCH (2003)
Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
IS Anand et al.
CIRCULATION (2003)
Comparison of omapatrilat chronic and enalapril in patients with heart failure - The omapatrilat versus enalapril randomized trial of utility in reducing events (OVERTURE)
M Packer et al.
CIRCULATION (2002)
The pregnancy hormone relaxin is a player in human heart failure
T Dschietzig et al.
FASEB JOURNAL (2001)
Glycogen synthase kinase 3β regulates GATA4 in cardiac myocytes
C Morisco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The β2-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-dependent coupling to phosphatidylinositol 3′-kinase
A Chesley et al.
CIRCULATION RESEARCH (2000)
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
JL Rouleau et al.
LANCET (2000)
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure.
WS Colucci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The Akt-glycogen synthase kinase 3β pathway regulates transcription of atrial natriuretic factor induced by β-adrenergic receptor stimulation in cardiac myocytes
C Morisco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
